These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22843201)

  • 21. Sildenafil therapy for pulmonary arterial hypertension associated with atrial septal defects.
    Lim ZS; Salmon AP; Vettukattil JJ; Veldtman GR
    Int J Cardiol; 2007 May; 118(2):178-82. PubMed ID: 17027100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension.
    Johnson RF; Loyd JE; Mullican AL; Fink CA; Robbins IM
    J Heart Lung Transplant; 2007 Apr; 26(4):363-9. PubMed ID: 17403478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of sildenafil treatment in pulmonary arterial hypertension: a systematic review.
    Wang RC; Jiang FM; Zheng QL; Li CT; Peng XY; He CY; Luo J; Liang ZA
    Respir Med; 2014 Mar; 108(3):531-7. PubMed ID: 24462476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Sildenafil improves right ventricular function in a cardiac transplant recipient].
    Paez RP; Araujo WF; Hossne NA; Neves AL; Vargas GF; Aguiar Lde F; Branco JN; Catani R; Buffolo E
    Arq Bras Cardiol; 2005 Feb; 84(2):176-8. PubMed ID: 15761645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphodiesterase 5 inhibitors in vascular systemic disorders.
    Allanore Y
    Joint Bone Spine; 2012 Jul; 79(4):338-40. PubMed ID: 22410367
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhaled NO and sildenafil combination in cardiac surgery patients with out-of-proportion pulmonary hypertension: acute effects on postoperative gas exchange and hemodynamics.
    Matamis D; Pampori S; Papathanasiou A; Papakonstantinou P; Tsagourias M; Galiatsou E; Koulouras V; Nakos G
    Circ Heart Fail; 2012 Jan; 5(1):47-53. PubMed ID: 22057829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sildenafil therapy for neonatal and childhood pulmonary hypertensive vascular disease.
    Humpl T; Reyes JT; Erickson S; Armano R; Holtby H; Adatia I
    Cardiol Young; 2011 Apr; 21(2):187-93. PubMed ID: 21138617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic applications of sildenafil citrate in the management of paediatric pulmonary hypertension.
    Leibovitch L; Matok I; Paret G
    Drugs; 2007; 67(1):57-73. PubMed ID: 17209664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase III, multicenter, collaborative, open-label clinical trial of sildenafil in Japanese patients with pulmonary arterial hypertension.
    Satoh T; Saji T; Watanabe H; Ogawa S; Takehara K; Tanabe N; Yamada N; Yao A; Miyaji K; Nakanishi N; Suzuki Y; Fujiwara T; Kuriyama T
    Circ J; 2011; 75(3):677-82. PubMed ID: 21304214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Marked improvement with sildenafil in a patient with idiopathic pulmonary arterial hypertension unresponsive to beraprost and sarpogrelate.
    Kawano H; Sengyoku H; Satoh O; Urabe S; Koide Y; Yano K
    Intern Med; 2007; 46(12):893-8. PubMed ID: 17575385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
    Michelakis ED; Tymchak W; Noga M; Webster L; Wu XC; Lien D; Wang SH; Modry D; Archer SL
    Circulation; 2003 Oct; 108(17):2066-9. PubMed ID: 14568893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology.
    D'Alto M; Romeo E; Argiento P; Sarubbi B; Santoro G; Grimaldi N; Correra A; Scognamiglio G; Russo MG; Calabrò R
    Int J Cardiol; 2012 Mar; 155(3):378-82. PubMed ID: 21081251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral sildenafil for persistent pulmonary hypertension early after congenital cardiac surgery in children.
    Nemoto S; Sasaki T; Ozawa H; Katsumata T; Kishi K; Okumura K; Mori Y; Umegaki O
    Eur J Cardiothorac Surg; 2010 Jul; 38(1):71-7. PubMed ID: 20206543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of pulmonary hypertension in children with chronic lung disease with newer oral therapies.
    Krishnan U; Krishnan S; Gewitz M
    Pediatr Cardiol; 2008 Nov; 29(6):1082-6. PubMed ID: 18594787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on the clinical utility of sildenafil in the treatment of pulmonary arterial hypertension.
    Ramani GV; Park MH
    Drug Des Devel Ther; 2010 May; 4():61-70. PubMed ID: 20531962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
    Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS
    J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of oral sildenafil for management of right ventricular dysfunction after pediatric heart transplantation.
    Singh RK; Richmond ME; Zuckerman WA; Lee TM; Giblin TB; Rodriguez R; Chen JM; Addonizio LJ
    Am J Transplant; 2014 Feb; 14(2):453-8. PubMed ID: 24354898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular effects of sildenafil in neonates and infants with congenital diaphragmatic hernia and pulmonary hypertension.
    Noori S; Friedlich P; Wong P; Garingo A; Seri I
    Neonatology; 2007; 91(2):92-100. PubMed ID: 17344658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sildenafil added to sitaxsentan in overcirculation-induced pulmonary arterial hypertension.
    Rondelet B; Dewachter L; Kerbaul F; Dewachter C; Hubloue I; Fesler P; Franck S; Remmelink M; Brimioulle S; Naeije R
    Am J Physiol Heart Circ Physiol; 2010 Oct; 299(4):H1118-23. PubMed ID: 20693396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary arterial hypertension caused by treatment with dasatinib for chronic myeloid leukemia -critical alert-.
    Sano M; Saotome M; Urushida T; Katoh H; Satoh H; Ohnishi K; Hayashi H
    Intern Med; 2012; 51(17):2337-40. PubMed ID: 22975544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.